These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 29561432

  • 1. Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.
    Bednarska K, Król E, Głowacka E, Romanowicz H, Szyłło K, Klink M, Sułowska Z, Nowak M.
    Medicine (Baltimore); 2018 Mar; 97(12):e0180. PubMed ID: 29561432
    [Abstract] [Full Text] [Related]

  • 2. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
    Kotowicz B, Fuksiewicz M, Sobiczewski P, Spiewankiewicz B, Jonska-Gmyrek J, Skrzypczak M, Kowalska M.
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
    Kristjansdottir B, Levan K, Partheen K, Sundfeldt K.
    Gynecol Oncol; 2013 Oct; 131(1):52-8. PubMed ID: 23891789
    [Abstract] [Full Text] [Related]

  • 4. A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
    Pils D, Tong D, Hager G, Obermayr E, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Van Gorp T, Mahner S, Concin N, Speiser P, Zeillinger R.
    BMC Cancer; 2013 Apr 03; 13():178. PubMed ID: 23551967
    [Abstract] [Full Text] [Related]

  • 5. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.
    Qiu J, Yu Y, Fu Y, Ye F, Xie X, Lu W.
    J Obstet Gynaecol Res; 2012 Apr 03; 38(4):651-7. PubMed ID: 22413879
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors).
    Gundogdu F, Soylu F, Erkan L, Tatli O, Mavi S, Yavuzcan A.
    Arch Gynecol Obstet; 2011 Jun 03; 283(6):1397-402. PubMed ID: 20645105
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
    Li QL, Wang CJ, Qi P, Zhang YX.
    Clin Transl Oncol; 2017 Oct 03; 19(10):1260-1267. PubMed ID: 28444641
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X, Zhang H, Cong H, Wang X, Ni H, Shen X, Ju S.
    Pathol Oncol Res; 2018 Oct 03; 24(4):739-744. PubMed ID: 29520570
    [Abstract] [Full Text] [Related]

  • 16. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM, Lou G.
    Zhonghua Zhong Liu Za Zhi; 2017 Sep 23; 39(9):676-680. PubMed ID: 28926896
    [Abstract] [Full Text] [Related]

  • 17. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008 Sep 23; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y, Yan Q, Li S, Li B, Feng Y.
    Cancer Biomark; 2016 Jun 07; 17(1):33-40. PubMed ID: 27314290
    [Abstract] [Full Text] [Related]

  • 20. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
    Lee M, Kim SW, Nam EJ, Yim GW, Kim S, Kim YT.
    Gynecol Oncol; 2011 Aug 07; 122(2):238-41. PubMed ID: 21531448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.